HSIC Henry Schein
- 68.280
- +2.100+3.17%
- 68.280
- 0.0000.00%
Henry Schein News
Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like
Clinician's Choice Launches MPa Universal
LONDON, Ontario--(BUSINESS WIRE)--Clinician's Choice is expanding their MPa family of adhesives with MPa Universal. MPa Universal offers a cost-effective and reliable solution for both direct and indi
S.M.I.L.E. Healthcare Pathway Program Announces Strategic Expansion With Leading Dental Industry Partners
The S.M.I.L.E. (Student Mentoring with Immersive Learning and Enrichment) Healthcare Pathway Program, a leader in advancing oral health equity, is pleased to announce the addition of several prominent organizations as
Insider Sale: Sr. VP & Chief Legal Officer Walter Siegel Sells Shares of Henry Schein Inc (HSIC)
Henry Schein(HSIC.US) Officer Sells US$287.19K in Common Stock
$Henry Schein(HSIC.US)$ Officer Siegel Walter sold 4,134 shares of common stock on Jun 6, 2024 at an average price of $69.47 for a total value of $287.19K.Source: Announcement What is statement of cha
Henry Schein (HSIC) Down 4.3% Since Last Earnings Report: Can It Rebound?
Form 144 | Henry Schein(HSIC.US) Officer Proposes to Sell 287.19K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 6, $Henry Schein(HSIC.US)$ Officer Siegel Walter intends to sell 4,134 shares of its common stock on Jun 6, with a total market value of approximately $287.19K. Source:
Gavin Poole Appointed New CFO of PracticeTek
SAN DIEGO--(BUSINESS WIRE)--PracticeTek, a leading provider of innovative software solutions for the healthcare industry, has announced the appointment of Gavin Poole as Chief Financial Officer (CFO).
Sell Ideas in Staples and Health Care - Oppenheimer
Peering Into Henry Schein's Recent Short Interest
Henry Schein's (NYSE:HSIC) short percent of float has risen 5.32% since its last report. The company recently reported that it has 5.31 million shares sold short, which is 4.75% of all regular shares
Here's Why Henry Schein (HSIC) Is a Strong Value Stock
Align Technology, Henry Schein, Dentsply Sirona to Benefit From Dental Aligners Growth
Possible Bearish Signals With Henry Schein Insiders Disposing Stock
Many Henry Schein, Inc. (NASDAQ:HSIC) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When evaluating insider transactions, knowing whether i
Henry Schein to Present at Investor Conferences in June 2024
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor
Why Henry Schein (HSIC) Is a Top Momentum Stock for the Long-Term
Henry Schein Mobilizes Support for Recovery Efforts in Brazil
Company Commits Over $200,000 in Cash and Health Care Product Donations, Matches Employee Contributions In the wake of the devastation caused by the flooding in Brazil, Henry Schein, Inc. (NASDAQ:HSIC) is raising
Henry Schein Extends Special Olympics Sponsorship Through 2025
Henry Schein (HSIC) said Monday it has extended its partnership with Special Olympics through 2025. The company said it will provide oral health and medical care products to athletes at Special Olympi
Looking Into Henry Schein's Recent Short Interest
Henry Schein's (NYSE:HSIC) short percent of float has fallen 4.69% since its last report. The company recently reported that it has 5.24 million shares sold short, which is 4.67% of all regular shares
Henry Schein Is Maintained at Outperform by Barrington Research
Henry Schein Is Maintained at Outperform by Barrington Research
Henry Schein Price Target Raised to $92.00/Share From $90.00 by Barrington Research
Henry Schein Price Target Raised to $92.00/Share From $90.00 by Barrington Research
Analysis
Price Target
No Data
